RIGEL PHARMACEUTICALS INC 4
4 · RIGEL PHARMACEUTICALS INC · Filed Feb 6, 2017
Insider Transaction Report
Form 4
Masuda Esteban
Sr. VP Research
Transactions
- Award
Stock Option (Right to Buy)
2017-02-02+50,000→ 50,000 totalExercise: $2.11Exp: 2027-02-02→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The shares vest monthly over four (4) years from January 1, 2017.